Alt üriner sistem semptomları ile serum PSA seviyeleri ve histolojik prostatit arasındaki ilişki.
Amaç: Bu çalışmanın amacı histolojik olarak tespit edilen prostatik inflamasyonun serum PSA seviyeleri ve alt üriner sistem semptomları üzerine olan etkilerini araştırmaktı.
___
- Erdemir F, Parlaktaş BS, Uluocak N. “Pros- tatitlerin Patofizyolojisi, Tanısı, Tedavisi ve Değerlendirilmesindeki Yenilikler,” Üroloji Bülteni, 2007; 18: 147-155
- 2. Nickel JC: Prevalence of Prostatitis Like Syndromes in a Population Based Study Using the National Insti- tutes of Health Chronic Prostatitis Symptom Index. J Urol, 2001; 165: 842-845
- McNeal JE. Regional morphology and pathology of the prostate. Am J Clin Pathol. 1968 ; 49:347-57
- Xie H, Huang HC, Yang YR et al. Expressions of bacte- rial 16S rRNA, IL-1beta, TNF-alpha and NGF in prostate tissues. Zhonghua Nan Ke Xue. 2010; 16: 40-3
- Krieger JN, Nyberg L Jr, Nickel JC. NIHconsensus deŞnition and classiŞcation of prostatitis. JAMA 1999; 282:236–237
- Cuneyt Ozden, Levent Ozdal, Ozer Guzel et al. The correlation between serum prostate speciŞc antigen levels and asymptomatic inflammatory prostatitis Int Urol Nephrol 2007; 39:859–863
- 7. Hasui Y, Marutsuka K, Asada Y. et al. Relationship between serum prostate specific antigen and histo- logical prostatitis in patients with benign prostatic hy- perplasia. Prostate. 1994; 25: 91-6
- Sciarra A, Di Silverio F, Salciccia S et al. Inflammation and chronic prostatic diseases: evidence for a link? Eur Urol. 2007; 52: 964-72
- Piovesan AC, Freire Gde C, Torricelli FC et al. Incidence of histological prostatitis and its correlation with PSA density. Clinics (Sao Paulo). 2009; 64: 1049-51.
- De Marzo AM, Nakai Y, Nelson WG. Inflammation, at- rophy, and prostate carcinogenesis. Urol Oncol. 2007; 25: 398-400
- Yaman O, Göğüş C, Tulunay O et al. Increased pros- tate-specific antigen in subclinical prostatitis: the role of aggressiveness and extension of inflammation. Urol Int. 2003; 71: 160-4.
- Nadler RB, Humphrey PA, Smith DS et al. Effect of in- flammation and benign prostatic hyperplasia on el- evated serum prostate specific antigen levels. J Urol. 1995; 154: 407-13.
- van Vuuren SP, Heyns CF, Zarrabi AD. Significance of histological prostatitis in patients with urinary reten- tion and underlying benign prostatic hyperplasia or adenocarcinoma of the prostate. BJU Int. 2012; 109: 1194-7. See comment in PubMed Commons below
- Stancik I, Lüftenegger W, Klimpfinger M. et al. Effect of NIH-IV prostatitis on free and free-to-total PSA. Eur Urol. 2004; 46: 760-4.
- Roehrborn CG. Definition of at-risk patients: baseline variables. BJU Int 2006; 97: 7-11.
- Nickel JC, Roehrborn CG, O’leary MP et al. Examina- tion of the relationship between symptoms of prosta- titis and histological inflammation: baseline data from the REDUCE chemoprevention trial. J Urol. 2007; 178: 896-900
- Mishra VC, Allen DJ, Nicolaou C et al. Does intrapro- static inflammation have a role in the pathogenesis and progression of benign prostatic hyperplasia? BJU Int. 2007; 100: 327-31.